Related Experiment Video

Updated: Aug 17, 2026

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
10:48

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

Pathogenesis and potential antiviral therapy of complications of smallpox vaccination

Mike Bray1

  • 1Biodefense Clinical Research Branch, Office of Clinical Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA. mbray@niaid.nih.gov

Antiviral Research
|May 14, 2003
PubMed

Insights

Smallpox vaccination can cause severe complications, especially in unvaccinated individuals. New antiviral therapies are needed to manage adverse events and protect vulnerable populations during potential mass vaccination campaigns.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Smallpox vaccination, halted in the US in 1972, leaves a significant portion of the population unvaccinated.
  • First-time vaccinees are at higher risk for adverse events, raising concerns for bioterrorism response strategies.
  • Individuals with atopic dermatitis, eczema, or compromised cell-mediated immunity are particularly susceptible to vaccinia complications.

Purpose of the Study:

  • To highlight the risks associated with smallpox vaccination, particularly in previously unvaccinated populations.
  • To emphasize the need for effective antiviral therapies to manage vaccinia virus complications.
  • To advocate for further research and clinical evaluation of new antiviral drugs for vaccinia infections.

Main Methods:

  • Review of historical vaccination complications and treatment modalities.
  • Analysis of risks associated with large-scale vaccination in naive populations.
  • Identification of vulnerable groups requiring special consideration for vaccination.

Main Results:

  • Smallpox vaccine complications range from mild to life-threatening, often linked to excessive vaccinia virus replication.
  • Existing treatments like vaccinia immune globulin (VIG) and methisazone lack placebo-controlled trial data.
  • New antiviral drugs require evaluation for human efficacy against vaccinia infections.

Conclusions:

  • Urgent need for laboratory and clinical studies to develop and validate effective antiviral treatments for vaccinia.
  • Proactive research is crucial to mitigate serious complications during future smallpox vaccination campaigns.
  • Protecting immunocompromised individuals and those with skin conditions is paramount.

More Related Videos

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection09:25

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection

Published on: May 24, 2020

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...